Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 1 3Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1CNS 1

Conditions

Neurofibromatosis 1 1Neoplasms 1Castration Sensitive Prostate Cancer 1

Interventions

pembrolizumab 257Cyclophosphamide 241Specimen Handling 198fludarabine 173Magnetic Resonance Spectroscopy 173Biopsy 147Nivolumab 120Carboplatin 97Radiotherapy 92Paclitaxel 85venetoclax 82Cisplatin 80Gemcitabine 79fludarabine phosphate 78Injections 68Ipilimumab 64Dexamethasone 62atezolizumab 59Bevacizumab 58Cetuximab 57Radiation 55Fluorouracil 55Azacitidine 55durvalumab 54Radiosurgery 52Temozolomide 47Rituximab 44Oxaliplatin 44Docetaxel 44Irinotecan 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Curcumin × 1 year × Clear all
NCT05363267 2026-06-01

NF-1, Nutraceutical Intervention

Masonic Cancer Center, University of Minnesota

Phase 1 Active not recruiting
23 enrolled
CNS

Neurofibromatosis 1

NCT06626230 2026-05-18

Safety of Anal Curcumin

Emory University

Phase 1 Recruiting
48 enrolled
Tumor-Agnostic

Neoplasms

NCT06044025 2026-01-15

A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

University of Arkansas

Phase 1 Recruiting
34 enrolled
Genitourinary

Castration Sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡